Evidence map›Paper›PMID 15187228›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells.

Zhiwen Zhang, Lital Alfonta, Feng Tian, Badry Bursulaya, Sean Uryu, David S King, Peter G Schultz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Biological Regulation StudiedAccounts of chemical research · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Expanding the Genetic Code for Neuronal Studies.Chembiochem : a European journal of chemical biology · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Expanding the Scope of Protein Synthesis Using Modified Ribosomes.Journal of the American Chemical Society · 2019
    Article
  18. Article
  19. Therapeutic applications of genetic code expansion.Synthetic and systems biotechnology · 2018
    Review
  20. The central role of tRNA in genetic code expansion.Biochimica et biophysica acta. General subjects · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhiwen ZhangDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Lital Alfonta
Feng Tian
Badry Bursulaya
Sean Uryu
David S King
Peter G Schultz
Genomics Institute of the Novartis Research Foundation · USScripps Research Institute · US

Funding

IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDSR01GM062159 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SCHULTZ, PETER G · 2001 to 2022
$8.2M
Protein Studies with an Expanded Genetic CodeF32GM066494 · NIGMS · SCRIPPS RESEARCH INSTITUTE · PI ZHANG, ZHIWEN JONATHAN · 2002 to 2003
$81k
NIGMS NIH HHS F32 GM066494NIGMS NIH HHS GM62159NIGMS NIH HHS GM66494NIGMS NIH HHS R01 GM062159
6 · The paper itself

Abstract

An orthogonal tryptophanyl-transfer RNA (tRNA) synthetase (TrpRS)-mutant opal suppressor tRNA(Trp) (mutRNA(UCA)(Trp)) pair was generated for use in mammalian cells. The anticodon loop of the Bacillus subtilis tRNA(Trp) was mutated to UCA, three positions in the D arm were mutated to generate an internal promoter sequence, and the mutRNA(UCA)(Trp) gene was inserted between the 5' and 3' flanking sequences of the tRNA(Trp-1) gene from Arabidopsis to enhance its expression in mammalian cells. In vitro aminoacylation assays and in vivo opal suppression assays showed that B. subtilis TrpRS (BsTrpRS) charges only the cognate mutRNA(UCA)(Trp) and no endogenous mammalian tRNAs. Similarly, the mutRNA(UCA)(Trp) is specifically charged by B. subtilis TrpRS and not by endogenous synthetases in mammalian cells. Site-directed mutagenesis was then used to alter the specificity of BsTrpRS to uniquely charge 5-hydoxy-l-tryptophan. The resulting mutant BsTrpRS-mutRNA(UCA)(Trp) pair allows the efficient and selective incorporation of 5-hydroxy-l-tryptophan into mammalian proteins in response to the codon, TGA. This amino acid can be used as a fluorescence probe and also undergoes electrochemical oxidation in situ to generate an efficient protein crosslinking.

Indexed as

5-HydroxytryptophanAnticodonArabidopsisBacillus subtilisBase SequenceCell LineCodonCross-Linking ReagentsEscherichia coliHumansModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedMutationNucleic Acid ConformationRNA, Transfer, Trp5-HydroxytryptophanAnticodonCodonCross-Linking ReagentsRNA, Transfer, TrpTryptophan-tRNA Ligase

Identifiers

PMID15187228
PMCPMC428441
OpenAlexW4242105567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.